Chemotherapy in Osteosarcoma: Basis for Application and Antagonism to Implementation; Early Controversies Surrounding its Implementation
- 1 August 1995
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 9 (4) , 825-840
- https://doi.org/10.1016/s0889-8588(18)30074-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Long-term evaluation of surgery followed by adjuvant adriamycin in osteogenic sarcomaEuropean Journal of Cancer and Clinical Oncology, 1987
- Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized studyEuropean Journal of Cancer and Clinical Oncology, 1986
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studiesCancer, 1983
- Full-lung tomograms and bone scanning in the initial work-up of patients with osteogenic sarcoma. A review of 126 casesEuropean Journal of Cancer and Clinical Oncology, 1982
- The therapy of osteosarcoma by intraarterial cis-platinum and limb preservationCardioVascular and Interventional Radiology, 1981
- Adjuvant chemotherapy in nonmetastatic osteosarcoma: A southwest oncology group studyMedical and Pediatric Oncology, 1980
- Amputation and Adriamycin in Primary OsteosarcomaNew England Journal of Medicine, 1974
- Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic SarcomaNew England Journal of Medicine, 1974
- The therapy of osteogenic sarcoma: Current status and thoughts for the futureJournal of Surgical Oncology, 1972